Skip to content

Hearing · house

Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule

2024-03-21 · 14:00

Source status: Scheduled

Committee

Location

2123, Rayburn House Office Building

Video

Witnesses

  1. Mr. Zach Rothstein, JD

    Executive Director

  2. Dr. Jeff Allen, PhD

    President and CEO

  3. Ms. Susan Van Meter

    President

  4. Dr. Dara L. Aisner, MD, PhD

    Medical Director, Colorado Molecular Correlates Laboratory

  5. Dr. Donald S. Karcher, MD, FCAP

    President

Documents

Source: https://api.congress.gov/v3/committee-meeting/118/house/117011